158 related articles for article (PubMed ID: 23595505)
1. Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.
Spector SA; Qin M; Lujan-Zilbermann J; Singh KK; Warshaw MG; Williams PL; Jean-Philippe P; Fenton T; Siberry GK;
Clin Vaccine Immunol; 2013 Jun; 20(6):900-6. PubMed ID: 23595505
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.
Siberry GK; Williams PL; Lujan-Zilbermann J; Warshaw MG; Spector SA; Decker MD; Heckman BE; Demske EF; Read JS; Jean-Philippe P; Kabat W; Nachman S;
Pediatr Infect Dis J; 2010 May; 29(5):391-6. PubMed ID: 20431379
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.
Lujan-Zilbermann J; Warshaw MG; Williams PL; Spector SA; Decker MD; Abzug MJ; Heckman B; Manzella A; Kabat B; Jean-Philippe P; Nachman S; Siberry GK;
J Pediatr; 2012 Oct; 161(4):676-81.e2. PubMed ID: 22622049
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine.
Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Johnson DR; Borrow R
Clin Vaccine Immunol; 2012 Oct; 19(10):1561-6. PubMed ID: 22855388
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.
Pine SO; McElrath MJ; Bochud PY
AIDS; 2009 Nov; 23(18):2387-95. PubMed ID: 19855253
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
[TBL] [Abstract][Full Text] [Related]
7. Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM
Tashani M; Badahdah AM; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Louth J; Rashid H; Borrow R; Booy R
Vaccine; 2019 Jun; 37(27):3562-3567. PubMed ID: 31128875
[TBL] [Abstract][Full Text] [Related]
8. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
[TBL] [Abstract][Full Text] [Related]
9. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.
Soriano-Sarabia N; Vallejo A; Ramírez-Lorca R; Rodríguez Mdel M; Salinas A; Pulido I; Sáez ME; Leal M
J Acquir Immune Defic Syndr; 2008 Oct; 49(2):128-35. PubMed ID: 18769358
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer study.
Al-Mazrou Y; Khalil M; Findlow H; Chadha H; Bosch Castells V; Johnson DR; Borrow R
Clin Vaccine Immunol; 2012 Jul; 19(7):999-1004. PubMed ID: 22552602
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.
Bröker M; Veitch K
Travel Med Infect Dis; 2010 Jan; 8(1):47-50. PubMed ID: 20188306
[TBL] [Abstract][Full Text] [Related]
12. A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents.
Muse D; Christensen S; Bhuyan P; Absalon J; Eiden JJ; Jones TR; York LJ; Jansen KU; O'Neill RE; Harris SL; Perez JL
Pediatr Infect Dis J; 2016 Jun; 35(6):673-82. PubMed ID: 26974889
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece.
Chatzi M; Papanikolaou J; Makris D; Papathanasiou I; Tsezou A; Karvouniaris M; Zakynthinos E
J Crit Care; 2018 Oct; 47():1-8. PubMed ID: 29860039
[TBL] [Abstract][Full Text] [Related]
15. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.
Kimura A; Toneatto D; Kleinschmidt A; Wang H; Dull P
Clin Vaccine Immunol; 2011 Mar; 18(3):483-6. PubMed ID: 21177912
[TBL] [Abstract][Full Text] [Related]
17. Analysis of TLR2, TLR4, and TLR9 single nucleotide polymorphisms in children with bacterial meningitis and their healthy family members.
Gowin E; Świątek-Kościelna B; Kałużna E; Nowak J; Michalak M; Wysocki J; Januszkiewicz-Lewandowska D
Int J Infect Dis; 2017 Jul; 60():23-28. PubMed ID: 28487240
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
Messaritakis I; Stogiannitsi M; Koulouridi A; Sfakianaki M; Voutsina A; Sotiriou A; Athanasakis E; Xynos E; Mavroudis D; Tzardi M; Souglakos J
PLoS One; 2018; 13(6):e0197327. PubMed ID: 29883450
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Oster P; Borrow R
Vaccine; 2014 Sep; 32(43):5715-21. PubMed ID: 25151042
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
Jonker EFF; van Ravenhorst MB; Berbers GAM; Visser LG
Vaccine; 2018 Jun; 36(26):3727-3732. PubMed ID: 29778515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
